María Nayeli Acosta-Gutiérrez, Julia Del Carmen Rodríguez-García, David Manuel Miranda-Canteros, Célida Duque-Molina, Ernesto Krug-Llamas, Alma Belen Membrila-Torres, Beatriz Nohemi Aguirre-Mendoza, Itzel Valtierra-Martinez, Joel Bailon-Brito, Diego Salomón Balcón-Caro
{"title":"[The Pierde Kilos, Gana Vida strategy, scope and prospects].","authors":"María Nayeli Acosta-Gutiérrez, Julia Del Carmen Rodríguez-García, David Manuel Miranda-Canteros, Célida Duque-Molina, Ernesto Krug-Llamas, Alma Belen Membrila-Torres, Beatriz Nohemi Aguirre-Mendoza, Itzel Valtierra-Martinez, Joel Bailon-Brito, Diego Salomón Balcón-Caro","doi":"10.5281/zenodo.13306787","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The Pierde Peso, Gana Vida (Lose Weight, Gain Life) strategy is granted to patients with overweight or obesity, it started in 2022 with the purpose of ordering, integrating and making efficient actions in the care of overweight and obesity, however, its effectiveness is unknown.</p><p><strong>Objective: </strong>To analyze the changes in the following parameters: body weight, waist circumference, glucose, cholesterol and triglycerides in patients who received the strategy in the 35 IMSS state offices during the two semesters of 2022.</p><p><strong>Material and methods: </strong>A retrospective cohort study was conducted including 76,760 patients incorporated into the strategy in the two semesters of 2022. Trend analysis was performed before and after each semester of intervention. Analytical statistics were used for related samples with Student's t-test. SPPSS v25 software was used for data analysis.</p><p><strong>Results: </strong>Patients who received this strategy in each semester presented significant decrease in the parameters: body weight, waist circumference, glucose, cholesterol and triglycerides.</p><p><strong>Conclusions: </strong>The Pierde Peso, Gana Vida strategy makes the actions in obesity care efficient and allows achieving good results in the beneficiaries.</p>","PeriodicalId":94200,"journal":{"name":"Revista medica del Instituto Mexicano del Seguro Social","volume":"62 6","pages":"1-5"},"PeriodicalIF":0.0000,"publicationDate":"2024-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista medica del Instituto Mexicano del Seguro Social","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5281/zenodo.13306787","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background: The Pierde Peso, Gana Vida (Lose Weight, Gain Life) strategy is granted to patients with overweight or obesity, it started in 2022 with the purpose of ordering, integrating and making efficient actions in the care of overweight and obesity, however, its effectiveness is unknown.
Objective: To analyze the changes in the following parameters: body weight, waist circumference, glucose, cholesterol and triglycerides in patients who received the strategy in the 35 IMSS state offices during the two semesters of 2022.
Material and methods: A retrospective cohort study was conducted including 76,760 patients incorporated into the strategy in the two semesters of 2022. Trend analysis was performed before and after each semester of intervention. Analytical statistics were used for related samples with Student's t-test. SPPSS v25 software was used for data analysis.
Results: Patients who received this strategy in each semester presented significant decrease in the parameters: body weight, waist circumference, glucose, cholesterol and triglycerides.
Conclusions: The Pierde Peso, Gana Vida strategy makes the actions in obesity care efficient and allows achieving good results in the beneficiaries.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
